UK recommends under 30s receive alternative COVID-19 vaccine

The United Kingdom’s drug regulator has found a possible link between the AstraZeneca vaccine and rare blood clotting issues.

The European Medicines Agency has listed blood clotting as a “very rare” side effect of the AstraZeneca jab, but insists the benefits still far outweigh the risks.

A review conducted by the drug regulator found 79 people had suffered blood clots after being administered the shot by the end of March, while 19 had died.


Due to the small risk, the UK is now recommending that healthy people aged between 18-29 be offered alternative jabs.

However, they’re still urging other age groups to continue to receive the AstraZeneca vaccine.

“We will follow today’s updated advice, which should allow people of all ages to continue to have full confidence in vaccines, helping us save lives and cautiously return towards normality,” UK Prime Minister Boris Johnson said.

The Australian Government has now asked the Therapeutic Goods Administration to look into the latest findings from the UK.

Despite the concerns, Queensland Premier Annastacia Palaszczuk has told Sunrise she believes “everyone does have confidence in the vaccine rollout”.

“Because we need to make sure that people get vaccinated… We have been in this COVID pandemic and people want to see a light at the end of the tunnel,” the Premier said.

“But in light of the concerns we have heard today I think it is only fitting that the Prime Minister has asked the TGA to have a look at this and I’m quite sure he will give us a thorough briefing at National Cabinet when we meet tomorrow.

“These are real issues and concerns coming out of Europe, and we need to make sure that our health authorities here are having a very close look at it and I have every confidence the Prime Minister will look at these issues very very closely.”